Antonio Farina

Saint-claude-de-diray, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: August 10, 2026

Isolated Peripheral Nervous System Presentation in Ma/Ma2-Associated Autoimmunity.

Isolated Peripheral Nervous System Presentation in Ma/Ma2-Associated Autoimmunity.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 23, 2026

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Immune checkpoint inhibitor neurotoxicity: long-term outcomes with focus on 1-year neurological sequelae.

Journal: Journal for immunotherapy of cancer

Published: May 28, 2026

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Clinical Features and Biomarkers Associated With Intensive Care-Dependent Refractory NMDAR Encephalitis: A Retrospective Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: February 13, 2026

Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders: A French Cohort Study.

Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders: A French Cohort Study.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 07, 2026

Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease.

Serum Neurofilament Light Chain Correlates With Clinical Severity and Predicts Mortality in Anti-IgLON5 Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 08, 2025

Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Immune Checkpoint Inhibitors Trigger and Exacerbate Anti-CV2/CRMP5 Paraneoplastic Neurologic Syndromes.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 18, 2025

Anti-AK5 limbic encephalitis in a patient with pleural mesothelioma.

Anti-AK5 limbic encephalitis in a patient with pleural mesothelioma.

Journal: Journal of neurology

Published: July 10, 2025

Relapses in Anti-NMDAR Encephalitis: Clinical Characterization and Predictive Features.

Relapses in Anti-NMDAR Encephalitis: Clinical Characterization and Predictive Features.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 18, 2025

Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies.

Clinical and tumor features of patients with immune checkpoint inhibitor-related neurological disorders and anti-Yo antibodies.

Journal: Therapeutic advances in neurological disorders

Published: May 05, 2025

Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review.

Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review.

Journal: Journal of neuroimmunology

Published: April 29, 2025

Neurodegeneration and the immune system: lessons from autoimmune encephalitis.

Neurodegeneration and the immune system: lessons from autoimmune encephalitis.

Journal: Journal of neurology

Published: March 03, 2025

Showing 1-12 of 51

Last Updated: 09/26/2026